Hamartoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(44 intermediate revisions by 7 users not shown)
Line 1: Line 1:
{{Hamartoma}}
{{Hamartoma}}
{{CMG}}{{AE}}{{MV}}
{{CMG}}{{AE}}{{MV}} {{VKG}}


==Overview==
==Overview==


Hamartomas arise from connective tissue and are generally formed of [[cartilage]], [[fat]], and [[connective tissue]] cells, although they may include many other types of cells. They can be located in [[lung]] (most common), [[heart]], [[hypothalamus]], [[kidneys]], or [[spleen]]. The pathogenesis consists primarily of the disorganized replication of normal tissue cells. There are many genetic syndromes that cause multiple hamartomas, such as; Peutz-Jeghers syndrome, PTEN hamartoma tumour syndrome and [[Cowden’s syndrome]]. Genes involved in the pathogenesis of harmatomatous syndromes include: [[BMPR1A]], [[SMAD4]], [[PTEN]], and [[STK11]].<ref>Stojcev Z, Borun P, Hermann J, et al. Hamartomatous polyposis syndromes. Hered Cancer Clin Pract. 2013;11(1):4.</ref><ref name="radio1">Splenic hamartoma.Dr Henry Knipe et al Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015</ref>
Hamartomas usually arise from [[connective tissue]] and are generally composed of [[cartilage]], [[fat]], and [[connective tissue]] cells. Hamartomas can be found in the [[lung]]s (most common), [[heart]], [[hypothalamus]], [[kidneys]], or [[spleen]]. The [[pathogenesis]] primarily consist of disorganized replication of normal tissue cells. Many hereditary syndromes are associated with hamartomatous formation. These include [[Peutz-Jeghers syndrome]], PTEN hamartoma [[tumor]] syndrome, and [[Cowden's syndrome]]. [[Genes]] that are involved in the [[pathogenesis]] of hamartomatous syndromes include [[BMPR1A]], [[SMAD4]], [[PTEN]], and [[STK11]].


==Pathogenesis==
==Pathophysiology==
 
=== Pathogenesis ===
*Hamartomas occur in the same location as the normal tissue (in the tissue of its origin) as opposed to [[choristoma]]s, which grow in other tissues (different from its origin).
*Hamartomas occur in the same location as the normal tissue (in the tissue of its origin) as opposed to [[choristoma]]s, which grow in other tissues (different from its origin).
*Hamartomas grow along with, and at the same rate as, the organ from whose tissue they are made.<ref name="pmid18418855">{{cite journal |vauthors=Zakharov V, Schinstine M |title=Hamartoma of the lung |journal=Diagn. Cytopathol. |volume=36 |issue=5 |pages=331–2 |year=2008 |pmid=18418855 |doi=10.1002/dc.20790 |url=}}</ref>
*The [[pathogenesis]] primarily consists of disorganized replication of normal tissue cells. The underlying mechanisms for the replication abnormality are not fully understood.<ref name="radio1">Splenic hamartoma.Dr Henry Knipe et al Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015</ref>
*These benign tumors result from an abnormal formation of normal tissue, although the underlying reasons for the abnormality are not fully understood.
*Hamartomas arise from [[connective tissue]] and are generally formed of [[cartilage]], [[fat]], and [[connective tissue]] cells, although they may include many other types of cells.
*Hamartomas grow at the same rate as the normal cells of the organ.<ref name="pmid18418855">{{cite journal |vauthors=Zakharov V, Schinstine M |title=Hamartoma of the lung |journal=Diagn. Cytopathol. |volume=36 |issue=5 |pages=331–2 |year=2008 |pmid=18418855 |doi=10.1002/dc.20790 |url=}}</ref>
*These can be located in the [[lung]]s (most common), [[heart]], [[hypothalamus]], [[kidneys]], or [[spleen]].<ref name="radio1">Splenic hamartoma.Dr Henry Knipe et al Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015</ref> 
 
=== Bone-forming tumors ===
* Bone-forming [[tumors]] (bone islands) are most commonly located in the [[intramedullary]] bones of:<ref name="pmid7396066">{{cite journal |vauthors=McCarthy EF, Dorfman HD |title=Vascular and cartilaginous hamartoma of the ribs in infancy with secondary aneurysmal bone cyst formation |journal=Am. J. Surg. Pathol. |volume=4 |issue=3 |pages=247–53 |date=June 1980 |pmid=7396066 |doi= |url=}}</ref><ref name="pmid92857452">{{cite journal |vauthors=Balci P, Obuz F, Göre O, Yilmaz E, Demirpolat G, Aktug T, Kovanlikaya I |title=Aneurysmal bone cyst secondary to infantile cartilaginous hamartoma of rib |journal=Pediatr Radiol |volume=27 |issue=9 |pages=767–9 |date=September 1997 |pmid=9285745 |doi=10.1007/s002470050224 |url=}}</ref><ref name="pmid1409151">{{cite journal |vauthors=Cohen MC, Drut R, Garcia C, Kaschula RO |title=Mesenchymal hamartoma of the chest wall: a cooperative study with review of the literature |journal=Pediatr Pathol |volume=12 |issue=4 |pages=525–34 |date=1992 |pmid=1409151 |doi= |url=}}</ref>
** [[Pelvis]]
** [[Femur]]
** [[Humerus]] 
** [[Ribs]]
* Bone-forming [[tumors]] are masses that are small, white-yellow and round.
* Tumors greater than 2 cm in size are known as giant bone islands.
 
=== Cartilage-forming tumors ===
* It is understood that cartilage-forming tumors like [[osteochondroma]] is produced from abnormal cartilaginous epiphyseal growth plate tissue and abnormal regulation of cartilage proliferation.<ref name="pmid73960662">{{cite journal |vauthors=McCarthy EF, Dorfman HD |title=Vascular and cartilaginous hamartoma of the ribs in infancy with secondary aneurysmal bone cyst formation |journal=Am. J. Surg. Pathol. |volume=4 |issue=3 |pages=247–53 |date=June 1980 |pmid=7396066 |doi= |url=}}</ref><ref name="pmid9285745">{{cite journal |vauthors=Balci P, Obuz F, Göre O, Yilmaz E, Demirpolat G, Aktug T, Kovanlikaya I |title=Aneurysmal bone cyst secondary to infantile cartilaginous hamartoma of rib |journal=Pediatr Radiol |volume=27 |issue=9 |pages=767–9 |date=September 1997 |pmid=9285745 |doi=10.1007/s002470050224 |url=}}</ref><ref name="pmid10770690">{{cite journal |vauthors=Göre O, Kiliçalp A, Başdemir G, Ozer E, Aktuğ T |title=Cartilaginous hamartoma of the chest wall with secondary aneurysmal cyst-like areas in an infant: a case report |journal=Turk. J. Pediatr. |volume=41 |issue=1 |pages=139–42 |date=1999 |pmid=10770690 |doi= |url=}}</ref>
 
* Cartilage-forming tumors are termed as congenital error of epiphyseal development.
 
=== Fiber-forming tumors ===
* It is understood that fiber-forming tumors is produced from continued growth of fibrous [[Cortical bone|cortical]] defects that extrude into the [[medullary]] cavity.
* The most commonly involved bone are tibia and the femur.


===Lung===
===Lung===
 
*Lung hamartomas mostly arise from connective tissue and are generally formed of [[cartilage]], fat, and [[connective tissue cells]], although they may include many other types of [[cells]].  
*In general, most hamartomas occur in the [[lungs]].  
*About 5-8% of all solitary lung tumors and about 75% of all [[benign]] [[lung]] [[tumors]] are hamartomas.  
*About 5-8% of all solitary lung tumors and about 75% of all [[benign]] lung tumors are hamartomas.
*The majority of pulmonary hamartomas form from [[connective tissue]] on the outside of the lungs, although about 10% form in the linings of the bronchi.  
*They mostly arise from connective tissue and are generally formed of [[cartilage]], fat, and connective tissue cells, although they may include many other types of cells.  
*In the majority of patients, it can be difficult to distinguish hamartoma from [[malignancies]].<ref name="pmid18418855">{{cite journal |vauthors=Zakharov V, Schinstine M |title=Hamartoma of the lung |journal=Diagn. Cytopathol. |volume=36 |issue=5 |pages=331–2 |year=2008 |pmid=18418855 |doi=10.1002/dc.20790 |url=}}</ref>
*The majority of pulmonary hamartomas form of [[connective tissue]] on the outside of the lungs, although about 10% form in the linings of the bronchi.  
*Pulmonary hamartomas can be divided into two subtypes endobronchial and [[parenchymal]].
*In the majority of patients, it can be difficult to distinguish hamartoma from malignancies.<ref name="pmid18418855">{{cite journal |vauthors=Zakharov V, Schinstine M |title=Hamartoma of the lung |journal=Diagn. Cytopathol. |volume=36 |issue=5 |pages=331–2 |year=2008 |pmid=18418855 |doi=10.1002/dc.20790 |url=}}</ref>
*An endobronchial location is described in 3%–20% of all [[pulmonary]] hamartomas. This subtype is mainly composed of [[cartilage]] and [[fibrous tissue]].  
*Pulmonary hamartomas can be divided into two subtypes: endobronchial and parenchymal.
*Endobronchial hamartomas typically contain more [[fat]] tissue than [[parenchymal]] hamartomas.
*An endobronchial location is described in 3%–20% of all pulmonary hamartomas. This subtype is mainly composed of cartilage and fibrous tissue.  
*Endobronchial hamartomas typically contain more fat tissue than parenchymal hamartomas.


===Heart===
===Heart===
 
*Cardiac [[rhabdomyomas]] are hamartomas comprised of altered [[cardiac myocytes]] that contain large vacuoles and [[glycogen]].
*Cardiac [[rhabdomyomas]] are hamartomas comprised of altered cardiac myocytes that contain large vacuoles and [[glycogen]].  
*Cardiac hamartomas arises from the striated muscle cells (cardiac myocytes), which are normally involved in the coordinated contractions of cardiac muscle cells.
*There is a strong association between cardiac rhabdomyomas and tuberous sclerosis (characterized by hamartomas of the central nervous system, kidneys and [[skin]], as well as pancreatic cysts; 25-50% of patients with cardiac [[rhabdomyomas]] will have [[tuberous sclerosis]], and up to 100% of patients with tuberous sclerosis will have cardiac masses by [[echocardiography]].<ref>Stojcev Z, Borun P, Hermann J, et al. Hamartomatous polyposis syndromes. Hered Cancer Clin Pract. 2013;11(1):4.</ref><ref name="kumar">Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Elsevier Health Sciences; 2012.</ref>
*Development of [[cardiac]] hamartomas is the result of multiple genetic mutations.
*Cardiac hamartoma symptoms depend on the size of the tumor, location relative to the conduction system, and whether it obstructs blood flow.
*Mutations in the [[TSC1]] or [[TSC2]] genes are related with [[tuberous sclerosis]].  
*Symptoms are usually from congestive heart failure.  If patients survive [[infancy]], their tumors may regress spontaneously; resection in symptomatic patients has good results.
*There is a strong association between [[cardiac]] rhabdomyomas and tuberous sclerosis (characterized by hamartomas of the [[central nervous system]], kidneys and [[skin]], as well as pancreatic cysts; 25-50% of patients with cardiac [[rhabdomyomas]] will have [[tuberous sclerosis]].
*Cardiac hamartoma symptoms will depend on the size of the [[tumor]] and location relative to the conduction system.
*For more information on heart hamartoma, See [[Rhabdomyoma|here]].


===Hypothalamus===
===Hypothalamus===
 
*[[Hypothalamic]] hamartoma is a benign tumor composed of disorganized collections of [[neurons]] and [[glia]].
*A hypothalamic or tuber cinereum hamartoma is benign non neoplasic heterotopia in the brain that typically occurs in the region of the hypothalamus, arising from the tuber cinereum, a part of the hypothalamus located between the mamillary bodies and the optic chiasm.
*[[Hypothalamic]] hamartoma is a non-neoplasic heterotopia that typically occurs in the region of the [[hypothalamus]]. This tumor arises from the tuber cinereum, a part of the [[hypothalamus]] located between the mamillary bodies and the [[optic chiasm]].
*Unlike other hamartomas, [[hypothalamic hamartoma]] is symptomatic;  it most often causes [[gelastic]] [[seizures]], and can cause visual problems, other seizures, rage disorders associated with hypothalamic diseases, and early onset of puberty. 
*Unlike other hamartomas, [[hypothalamic hamartoma]] is symptomatic;  it most often causes [[gelastic]] [[seizures]], visual problems, and rage disorders associated with hypothalamic diseases.
*The symptoms typically begin in early infancy and are progressive, often into general [[cognitive]] and/or functional disability.<ref>Zhu M, Maeda M, Lee GJ, and Yuh WTC: Chapter 53. Sellar Lesions. In: Stark DD. Bradley WG. (eds): Magnetic Resonance Imaging. (ed 3)St. Louis:Mosby,1999, pp 1225–1230</ref>
*For more information on [[hypothalamic]] hamartoma, See [[Hypothalamic hamartoma|here]]
*For more information on hypothalamic hamartoma, See [[Hypothalamic hamartoma|here]]


===Kidneys, spleen, and other vascular organs===
===Kidneys, spleen, and other vascular organs===


*Spleen and kidney hamartomas may impinge on blood vessels, resulting in a risk of serious bleeding.  
*[[Spleen]] and [[kidney]] hamartomas may impinge on [[blood vessels]], resulting in a risk of serious [[bleeding]].  
*Because hamartoma typically lacks elastic tissue, it may lead to the formation of aneurysms and thus possible [[hemorrhage]]. When a hamartoma impinges into a major [[blood vessel]], such as the [[renal artery]], hemorrhage may be life-threatening.<ref name="radio1">Splenic hamartoma.Dr Henry Knipe et al Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015</ref>
*Because hamartoma typically lacks [[elastic tissue]], it may lead to the formation of [[aneurysms]] and thus possible [[hemorrhage]]. When a hamartoma impinges into a major [[blood vessel]], such as the [[renal artery]], hemorrhage may be life-threatening.<ref name="radio1">Splenic hamartoma.Dr Henry Knipe et al Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015</ref>
*Hamartoma of the kidney is also called [[angiomyolipoma]] and can be associated with [[tuberous sclerosis]].   
*Hamartoma of the kidney is also called [[angiomyolipoma]] and can be associated with [[tuberous sclerosis]].   
*Spleen hamartomas are often associated with hematologic abnormalities and spontaneous rupture.
*Spleen hamartomas are often associated with [[hematologic]] abnormalities and spontaneous rupture.
*For more information on angiomyolipoma, See [[Angiomyolipoma|here]]
*For more information on [[angiomyolipoma]], See [[Angiomyolipoma|here]].


==Genetics==
==Genetics==
Line 50: Line 71:
:*[[PTEN]]
:*[[PTEN]]
:*[[STK11]]
:*[[STK11]]
==Associated Conditions==
==Associated Conditions==
*Many hereditary syndromes are associated with hamartomatous formation, these include:<ref name="pmid9140396">{{cite journal| author=Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z et al.| title=Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. | journal=Nat Genet | year= 1997 | volume= 16 | issue= 1 | pages= 64-7 | pmid=9140396 | doi=10.1038/ng0597-64 | pmc= | url= }} </ref>  
*Hereditary syndromes associated with hamartomatous formation include:<ref name="pmid9140396">{{cite journal| author=Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z et al.| title=Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. | journal=Nat Genet | year= 1997 | volume= 16 | issue= 1 | pages= 64-7 | pmid=9140396 | doi=10.1038/ng0597-64 | pmc= | url= }} </ref>  
**[[Juvenile polyposis syndrome]]
**[[Juvenile polyposis syndrome]]
**[[Peutz-Jeghers syndrome]]
**[[Peutz-Jeghers syndrome]]
**Hereditary mixed polyposis syndrome
**Hereditary mixed [[polyposis]] syndrome
**PTEN hamartoma tumour syndrome
**PTEN hamartoma tumor syndrome
**[[Tuberous sclerosis]]
**[[Tuberous sclerosis]]
**[[Cowden’s syndrome]]
**[[Cowden syndrome]]
**Bannayan-Riley-Ruvalcaba syndrome
**Bannayan-Riley-Ruvalcaba syndrome
===Cowden Syndrome===
*Cowden syndrome is a serious genetic disorder characterized by multiple hamartomas.<ref name="pmid9140396">{{cite journal| author=Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z et al.| title=Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. | journal=Nat Genet | year= 1997 | volume= 16 | issue= 1 | pages= 64-7 | pmid=9140396 | doi=10.1038/ng0597-64 | pmc= | url= }} </ref>
*Usually patients with Cowden syndrome demonstrate [[skin]] hamartomas, and commonly (about 66% of cases) hamartoma of the [[thyroid gland]].  Additional growths can form in many parts of the body, especially in [[mucosa]], the GI tract, [[bone]]s, CNS, the [[eye]]s, and the [[genitourinary tract]].  The hamartomas themselves may cause symptoms or even death, but morbidity is more often associated with increased occurrence of [[malignancies]], usually in the [[breast]] or thyroid.
*For more information on cowden syndrome, See [[Cowden syndrome|here]]
===Tuberous Sclerosis===
*Tuberous sclerosis is a syndrome caused by potentially by more than 900 mutations of the tumor suppressor genes for [[tuberin]] (TSC2) and hamartin (TSC1) that cause abnormal cellular signaling through the [[rapamycin]] complex 1.
*Tuberous sclerosis is characterized by multiple hamartomas, [[angiomyolipoma]]s (in 80%), and lymphangioleiomyomatosis.
*Important clinical features include: [[epilepsy]], learning difficulties, and skin tumors.
*For more information on tuberous sclerosis, See [[Tuberous sclerosis|here]]
===Peutz-Jeghers Syndrome===
*Peutz-Jeghers syndrome is an [[autosomal dominant]] disorder characterised by the concurrence of hamartomatous intestinal polyps with mucocutaneous melanotic macules usually on the lips, buccal mucosa, and digits.
*The polyps are usually benign, but there is a 15x increase in the risk of colorectal and other cancers compared to the general population.
*Females are more likely to develop granulosa cell ovarian tumours.
*Cancers of the pancreas, stomach, and even [[multiple myeloma]] are associated. It is caused by mutations of the STK11 gene at 19p13.3.<ref>Peutz-Jeghers syndrome. http://www.ganfyd.org/index.php?title=Peutz-Jeghers_syndrome Accessed on December 09,2015</ref>
*For more information on Peutz-Jeghers syndrome, See [[Peutz-Jeghers syndrome|here]]


==Gross Pathology==
==Gross Pathology==
Line 86: Line 85:
*On gross pathology, a hallmark feature of hamartoma is a well-circumscribed mass that may show a variegated yellow and white appearance, which corresponds to fat and cartilage, respectively.<ref name="kumar">Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Elsevier Health Sciences; 2012.</ref>
*On gross pathology, a hallmark feature of hamartoma is a well-circumscribed mass that may show a variegated yellow and white appearance, which corresponds to fat and cartilage, respectively.<ref name="kumar">Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Elsevier Health Sciences; 2012.</ref>
*Hamartomas are unencapsulated, lobulated tumors with connective tissue septa.  
*Hamartomas are unencapsulated, lobulated tumors with connective tissue septa.  
*Tumoral size ranges between 1 and 3 cm in diameter at the time of diagnosis.
*Tumor size ranges between 1 and 3 cm in diameter at the time of diagnosis.


==Microscopic Pathology==
==Microscopic Pathology==
Line 92: Line 91:
*On microscopic pathology, hamartomas have benign tumors features such as disorganized (non-neoplastic) growth, tissue of the region within it is found, and no invasion to surrounding tissue or structures.<ref name="kumar">Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Elsevier Health Sciences; 2012.</ref>
*On microscopic pathology, hamartomas have benign tumors features such as disorganized (non-neoplastic) growth, tissue of the region within it is found, and no invasion to surrounding tissue or structures.<ref name="kumar">Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Elsevier Health Sciences; 2012.</ref>
*Common findings include:  
*Common findings include:  
*[[Cartilage]] single cells in lacunae surrounded by abundant matrix and paucicellular vis-a-vis malignant lesions
:*[[Cartilage]] single cells in lacunae surrounded by abundant matrix and paucicellular vis-a-vis malignant lesions
*[[Fat]] ([[adipocytes]])
:*[[Fat]] ([[adipocytes]])
*Respiratory epithelium (columnar epithelium with cilia), only present in lung hamartoma
:*Respiratory epithelium (columnar epithelium with cilia), only present in lung hamartoma


==Gallery==
==Gallery==
Line 116: Line 115:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Surgery]]

Latest revision as of 04:12, 5 April 2019

Hamartoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamartoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamartoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamartoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamartoma pathophysiology

CDC on Hamartoma pathophysiology

Hamartoma pathophysiology in the news

Blogs on Hamartoma pathophysiology

Directions to Hospitals Treating Hamartoma

Risk calculators and risk factors for Hamartoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2] Vamsikrishna Gunnam M.B.B.S [3]

Overview

Hamartomas usually arise from connective tissue and are generally composed of cartilage, fat, and connective tissue cells. Hamartomas can be found in the lungs (most common), heart, hypothalamus, kidneys, or spleen. The pathogenesis primarily consist of disorganized replication of normal tissue cells. Many hereditary syndromes are associated with hamartomatous formation. These include Peutz-Jeghers syndrome, PTEN hamartoma tumor syndrome, and Cowden's syndrome. Genes that are involved in the pathogenesis of hamartomatous syndromes include BMPR1A, SMAD4, PTEN, and STK11.

Pathophysiology

Pathogenesis

  • Hamartomas occur in the same location as the normal tissue (in the tissue of its origin) as opposed to choristomas, which grow in other tissues (different from its origin).
  • The pathogenesis primarily consists of disorganized replication of normal tissue cells. The underlying mechanisms for the replication abnormality are not fully understood.[1]
  • Hamartomas arise from connective tissue and are generally formed of cartilage, fat, and connective tissue cells, although they may include many other types of cells.
  • Hamartomas grow at the same rate as the normal cells of the organ.[2]
  • These can be located in the lungs (most common), heart, hypothalamus, kidneys, or spleen.[1]

Bone-forming tumors

Cartilage-forming tumors

  • It is understood that cartilage-forming tumors like osteochondroma is produced from abnormal cartilaginous epiphyseal growth plate tissue and abnormal regulation of cartilage proliferation.[6][7][8]
  • Cartilage-forming tumors are termed as congenital error of epiphyseal development.

Fiber-forming tumors

  • It is understood that fiber-forming tumors is produced from continued growth of fibrous cortical defects that extrude into the medullary cavity.
  • The most commonly involved bone are tibia and the femur.

Lung

  • Lung hamartomas mostly arise from connective tissue and are generally formed of cartilage, fat, and connective tissue cells, although they may include many other types of cells.
  • About 5-8% of all solitary lung tumors and about 75% of all benign lung tumors are hamartomas.
  • The majority of pulmonary hamartomas form from connective tissue on the outside of the lungs, although about 10% form in the linings of the bronchi.
  • In the majority of patients, it can be difficult to distinguish hamartoma from malignancies.[2]
  • Pulmonary hamartomas can be divided into two subtypes endobronchial and parenchymal.
  • An endobronchial location is described in 3%–20% of all pulmonary hamartomas. This subtype is mainly composed of cartilage and fibrous tissue.
  • Endobronchial hamartomas typically contain more fat tissue than parenchymal hamartomas.

Heart

  • Cardiac rhabdomyomas are hamartomas comprised of altered cardiac myocytes that contain large vacuoles and glycogen.
  • Cardiac hamartomas arises from the striated muscle cells (cardiac myocytes), which are normally involved in the coordinated contractions of cardiac muscle cells.
  • Development of cardiac hamartomas is the result of multiple genetic mutations.
  • Mutations in the TSC1 or TSC2 genes are related with tuberous sclerosis.
  • There is a strong association between cardiac rhabdomyomas and tuberous sclerosis (characterized by hamartomas of the central nervous system, kidneys and skin, as well as pancreatic cysts; 25-50% of patients with cardiac rhabdomyomas will have tuberous sclerosis.
  • Cardiac hamartoma symptoms will depend on the size of the tumor and location relative to the conduction system.
  • For more information on heart hamartoma, See here.

Hypothalamus

Kidneys, spleen, and other vascular organs

Genetics

  • Genes involved in the pathogenesis of harmatomatous syndromes include:[9]

Associated Conditions

Gross Pathology

  • On gross pathology, a hallmark feature of hamartoma is a well-circumscribed mass that may show a variegated yellow and white appearance, which corresponds to fat and cartilage, respectively.[11]
  • Hamartomas are unencapsulated, lobulated tumors with connective tissue septa.
  • Tumor size ranges between 1 and 3 cm in diameter at the time of diagnosis.

Microscopic Pathology

  • On microscopic pathology, hamartomas have benign tumors features such as disorganized (non-neoplastic) growth, tissue of the region within it is found, and no invasion to surrounding tissue or structures.[11]
  • Common findings include:
  • Cartilage single cells in lacunae surrounded by abundant matrix and paucicellular vis-a-vis malignant lesions
  • Fat (adipocytes)
  • Respiratory epithelium (columnar epithelium with cilia), only present in lung hamartoma

Gallery

  • Low magnification micrograph of a pulmonary hamartoma. H&E stain.[12]

    Low magnification micrograph of a pulmonary hamartoma. H&E stain.[12]

  • Pulmonary hamartoma: the surrounding lung falls away from the well-circumscribed mass, a typical feature of these lesions. The hamartoma shows a variegated yellow and white appearance, which corresponds respectively to fat and cartilage.[12]

    Pulmonary hamartoma: the surrounding lung falls away from the well-circumscribed mass, a typical feature of these lesions. The hamartoma shows a variegated yellow and white appearance, which corresponds respectively to fat and cartilage.[12]

  • Gross pathology of pulmonary hamartoma.[12]

    Gross pathology of pulmonary hamartoma.[12]

  • Epithelial lined clefts within myxoid fibrous connective tissue.[12]

    Epithelial lined clefts within myxoid fibrous connective tissue.[12]

References

  1. ↑ 1.0 1.1 1.2 Splenic hamartoma.Dr Henry Knipe et al Radiopedia.http://radiopaedia.org/articles/pulmonary-hamartoma-1 Accessed on December 09, 2015
  2. ↑ 2.0 2.1 Zakharov V, Schinstine M (2008). "Hamartoma of the lung". Diagn. Cytopathol. 36 (5): 331–2. doi:10.1002/dc.20790. PMID 18418855.
  3. ↑ McCarthy EF, Dorfman HD (June 1980). "Vascular and cartilaginous hamartoma of the ribs in infancy with secondary aneurysmal bone cyst formation". Am. J. Surg. Pathol. 4 (3): 247–53. PMID 7396066.
  4. ↑ Balci P, Obuz F, Göre O, Yilmaz E, Demirpolat G, Aktug T, Kovanlikaya I (September 1997). "Aneurysmal bone cyst secondary to infantile cartilaginous hamartoma of rib". Pediatr Radiol. 27 (9): 767–9. doi:10.1007/s002470050224. PMID 9285745.
  5. ↑ Cohen MC, Drut R, Garcia C, Kaschula RO (1992). "Mesenchymal hamartoma of the chest wall: a cooperative study with review of the literature". Pediatr Pathol. 12 (4): 525–34. PMID 1409151.
  6. ↑ McCarthy EF, Dorfman HD (June 1980). "Vascular and cartilaginous hamartoma of the ribs in infancy with secondary aneurysmal bone cyst formation". Am. J. Surg. Pathol. 4 (3): 247–53. PMID 7396066.
  7. ↑ Balci P, Obuz F, Göre O, Yilmaz E, Demirpolat G, Aktug T, Kovanlikaya I (September 1997). "Aneurysmal bone cyst secondary to infantile cartilaginous hamartoma of rib". Pediatr Radiol. 27 (9): 767–9. doi:10.1007/s002470050224. PMID 9285745.
  8. ↑ Göre O, Kiliçalp A, Başdemir G, Ozer E, Aktuğ T (1999). "Cartilaginous hamartoma of the chest wall with secondary aneurysmal cyst-like areas in an infant: a case report". Turk. J. Pediatr. 41 (1): 139–42. PMID 10770690.
  9. ↑ Stojcev Z, Borun P, Hermann J, et al. Hamartomatous polyposis syndromes. Hered Cancer Clin Pract. 2013;11(1):4.
  10. ↑ Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z; et al. (1997). "Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome". Nat Genet. 16 (1): 64–7. doi:10.1038/ng0597-64. PMID 9140396.
  11. ↑ 11.0 11.1 Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. Elsevier Health Sciences; 2012.
  12. ↑ 12.0 12.1 12.2 12.3 Hamartoma. Libre Pathology.http://librepathology.org/wiki/index.php/Pulmonary_hamartoma Accessed on December 8, 2015


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Hamartoma_pathophysiology&oldid=1561482"